sections

Monday, 23 April 2018

Claire Ruckin' s stories

Sort by: Newest firstOldest firstA-ZZ-A

  • Sanofi logo

    Lenders make a beeline for €1bn-plus Zentiva financing

    Top News | 20 April 2018

    Goldman Sachs, JP Morgan and Morgan Stanley are in line to lead a financing in excess of €1bn to back private equity firm Advent International’s acquisition of European generic drugs company Zentiva, as other banks vie to win a spot on the aggressive deal, undeterred by its high leverage.

  • Flora

    Squeaky bum time for lev loan market

    Top News | 13 April 2018

    The European leveraged loan market’s €26bn deal pipeline is making bankers increasingly nervous amid weaker conditions in the global markets as the falling secondary loan price of Flora Food Group’s buyout debt points to tricky conditions ahead.

  • Techem's sale reaches final round

    Loans | 13 April 2018

    Macquarie has picked three suitors for a final bidding round for the sale of German metering group Techem, which may be valued at around €4bn (US$4.9bn).

  • Volume down 25% but pipeline builds

    Loans | 06 April 2018

    First-quarter syndicated lending in Europe, the Middle East and Africa fell 25% year-on-year to US$200bn from US$267bn, reflecting a fall in M&A activity and refinancing compared with the beginning of last year.

  • Banks pitch aggressive terms on refinancings

    Loans | 06 April 2018

    Bankers are pitching recapitalisation and refinancings to sponsors in a bid to maximise leverage, lower pricing and attain aggressive documentation for portfolio companies while a window of opportunity remains as longer-term visibility in Europe’s leveraged loan market starts to dwindle.

  • Flora

    Bankers pitch aggressive refinancings as uncertainty looms

    Ticker | 04 April 2018

    Bankers are pitching recapitalisation and refinancings to sponsors in a bid to maximise leverage, lower pricing and attain aggressive documentation for portfolio companies while a window of opportunity remains as longer term visibility in Europe’s leveraged loan market starts to dwindle.

  • AkzoNobel's logo is seen in Amsterdam

    Jumbo deal for Akzo Nobel unit LBO

    Top News | 29 March 2018

    Banks have lined up as much as €7.3bn-equivalent of debt to back the buyout of Akzo Nobel’s chemicals business, the latest jumbo cross-border leveraged financing to hit the loan and bond markets.

  • ECB lending guidelines 'toothless'

    Loans | 29 March 2018

    Several large leveraged buyouts have exceeded the six times leverage limit outlined by the European Central Bank’s guidance on leveraged lending, leading loan bankers to question just how effective the rules are.

  • A can of Akzo Nobe's Crown paint

    Banks line up €7.3bn debt for Akzo Nobel chem unit buyout - LPC

    Ticker | 27 March 2018

    Banks have lined up to €7.3bn-equivalent of debt financing to back the buyout of Akzo Nobel’s specialty chemicals business, banking sources said.

  • Banks, funds compete for second-lien

    Loans | 23 March 2018

    Banks and funds are competing for second-lien leveraged loans as they battle for higher-yielding assets to bolster their returns.

Show  10 per page20 per page50 per page